Eli Lilly and Company P/E Ratio 2007–2025
Eli Lilly and Company reported 46.67 of price-to-earnings ratio for fiscal 2025. That was 28.4% lower than fiscal 2024. Compared with fiscal 2020, the change was +98.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 46.67 | -28.4% |
| FY 2024 | 65.22 | -34.0% |
| FY 2023 | 98.78 | +91.4% |
| FY 2022 | 51.60 | +19.1% |
| FY 2021 | 43.33 | +84.3% |
| FY 2020 | 23.52 | +71.6% |
| FY 2019 | 13.71 | -59.1% |
| FY 2018 | 33.52 | — |
| FY 2017 | — | — |
| FY 2016 | 24.57 | -21.5% |
| FY 2015 | 31.30 | +23.7% |
| FY 2014 | 25.29 | +170.7% |
| FY 2013 | 9.34 | -9.1% |
| FY 2012 | 10.28 | +32.4% |
| FY 2011 | 7.76 | +47.0% |
| FY 2010 | 5.28 | -10.8% |
| FY 2009 | 5.92 | — |
| FY 2008 | — | — |
| FY 2007 | — | — |
Source: Eli Lilly and Company SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open LLY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Eli Lilly and Company reported 46.67 of price-to-earnings ratio for fiscal 2025. That was 28.4% lower than fiscal 2024. Compared with fiscal 2020, the change was +98.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Eli Lilly and Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEli Lilly and Company — frequently asked questions
What is Eli Lilly and Company's price-to-earnings ratio?
Eli Lilly and Company (LLY) reported price-to-earnings ratio of 46.67 for fiscal year 2025, per its SEC filings.
How has Eli Lilly and Company's price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, LLY's price-to-earnings ratio grew at roughly 12.2% per year (compound annual rate), from 5.92 to 46.67.
Where does this data come from?
Figures are computed from Eli Lilly and Company's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More LLY financial history
Full LLY fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →